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Abstract
Solid-phase synthesis of electrophilic oligodeoxynucleotides (ODNs) was achieved using dimethyl-Dmoc (dM-Dmoc) as amino
protecting group. Due to the high steric hindrance of the 2-(propan-2-ylidene)-1,3-dithiane side product from deprotection, the use
of excess nucleophilic scavengers such as aniline to prevent Michael addition of the side product to the deprotected ODN during
ODN cleavage and deprotection was no longer needed. The improved technology was demonstrated by the synthesis and characterization of five ODNs including three modified ones. The modified ODNs contained the electrophilic groups ethyl ester,
α-chloroamide, and thioester. Using the technology, the sensitive groups can be installed at any location within the ODN sequences
without using any sequence- or functionality-specific conditions and procedures.

Introduction
After over 60 years of intensive research, the challenges for
chemical oligodeoxynucleotide (ODN) synthesis have been
considered largely overcome [1-4]. However, this is only true
for unmodified ODNs at limited synthesis scales. For modified
ODNs that contain sensitive functionalities including those that
are unstable under acidic, basic and strongly nucleophilic conditions, many formidable challenges remain [2]. The reason is
that during ODN synthesis using traditional technologies, the
5'-hydroxy group of nucleoside monomers is protected with the

4,4'-dimethoxytrityl (DMTr) group, which has to be removed
with an acid in each synthetic cycle. The exo-amino groups of
nucleosides dA, dC and dG are protected with acyl groups, the
nascent ODN is anchored to a solid support via a base- or
nucleophile-cleavable linker, and in the most widely used phosphoramidite technology the phosphate groups are protected with
the 2-cyanoethyl group. These protecting groups and the linker
have to be cleaved under strongly basic and nucleophilic conditions. As a result, many sensitive groups including acetal, hemi-

1116

Beilstein J. Org. Chem. 2019, 15, 1116–1128.

acetal, vinyl ethers, enol ethers, aldehydes, esters, activated
esters, thioesters, aziridines, epoxides, alkyl halides, α-halocarbonyls, vinylpurines, methides and maleimides cannot or are
difficult to be incorporated into ODNs, or cannot be installed at
the desired locations in the ODNs. For example, to synthesize
oligos that contain the epigenetically modified 5-formylcytosine, the aldehyde group had to be protected as a cyclic acetal
instead of the more labile acyclic acetal [5,6]. The maleimide
group was incorporated into ODNs as a Diels–Alder adduct
with dimethylfuran. Besides the need of an additional step for
deprotection, only examples of 5'-end modification was given
probably due to the instability of the adduct under acidic conditions during ODN synthesis [7].
In recent years, applications of ODNs have extended to
emerging areas such as nanotechnology [8,9], antisense drug
development [10-12], DNA damage and repair [13,14], DNA
methylation and demethylation [15-18], DNA–protein interactions [19,20], CRISPR genome editing [21-23], DNA data
storage [24,25], synthetic biology [26], bioconjugation [27] and
others [28-30]. These applications frequently require modified
ODNs that contain a wide variety of functional groups including those that cannot survive known ODN synthesis, cleavage
and deprotection conditions. To meet these demands, some
work on developing new technologies suitable for the synthesis
of sensitive ODNs has been carried out [28,31]. A common
method is to use more labile acyl functions such as the
phenoxyacetyl group for amino protection and as linker to
enable deprotection and cleavage under milder basic conditions
[32]. The palladium-labile allyl groups were also used for
amino protection [33,34]. The o-nitrobenzyl function was used
as linker to enable photo cleavage [34]. However, these
methods are still not ideal. The phenoxyacetyl group and linker
still need nucleophilic cleavage. Palladium is expensive and
difficult to remove from ODN. Photoirradiation can damage
ODNs. The (p-nitrophenyl)ethyl (Npe) and (p-nitrophenyl)ethyloxycarbonyl (Npeoc) groups were also explored for sensitive
ODN synthesis under non-nucleophilic conditions [35-38]. The
requirement of the strong base DBU in aprotic solvents over
long hours in the presence of a nucleophilic scavenger for their
cleavage could limit their application. In addition, in some cases
the sequences synthesized by the method were short and the
yields of the ODNs were low [35-38]. In the literature, there are
also examples using post-synthesis modifications to introduce
sensitive groups to ODNs [12]. However, these methods are
case-specific, and their procedures are usually complicated. The
ODN synthesis method without nucleobase protection could be
considered for the incorporation of sensitive functionalities into
ODNs [39]. However, a linker that can be cleaved under mild
conditions is suitable for the purpose has not been identified.
More seriously, high selectivity of O-phosphitylation over

N-phosphitylation, which is crucial for practical applications
especially for the synthesis of ODNs approaching 20-mer or
longer, may not be easy to achieve.
To develop a universal technology for the synthesis of ODNs
that contain a wide variety of sensitive functionalities, we
recently reported the use of 1,3-dithian-2-ylmethoxycabonyl
(Dmoc) as protecting groups and linkers for ODN synthesis
[40,41]. Due to the low acidity of H-2 (pKa ≈31) in the Dmoc
function, these groups and linkers were expected to be stable
under ODN synthesis conditions. However, once the dithioketal
in the group is oxidized, the acidity of H-2 (pKa ≈12) is drastically increased [42,43]. Considering that the widely used Fmoc
protecting group, of which the H-9 has a pKa of ≈22 [42], can
be readily removed with a weak base such as piperidine, we
hypothesized that the oxidized Dmoc groups and linkers could
be cleaved under weakly basic and non-nucleophilic conditions
via β-elimination. Indeed, we found that the deprotection and
cleavage could be achieved by oxidation with sodium periodate
followed by treating with the mild base aniline at room temperature. Due to the mild deprotection and cleavage conditions, we
concluded that the technology was suitable for the synthesis of
sensitive ODNs that contain electrophilic groups. However, at
the current state of art one drawback of the technology is that
large excess aniline has to be used as a scavenger to prevent the
deprotection side product 1 from reacting with the deprotected
ODNs via Michael addition. Aniline is a weak nucleophile, but
using large excess is not ideal for a technology aimed to be
practically and universally useful. In this paper, we report the
use of dimethyl-Dmoc (dM-Dmoc), which we previously
studied for alkyl- and arylamine protections [44], in place of
Dmoc for nucleobase protection for ODN synthesis (Scheme 1).
Due to the steric hindrance of the side product 2 from deprotection, we found that a nucleophilic scavenger was no longer
needed during deprotection, and the β-elimination step could be
achieved using the non-nucleophilic weak base potassium
carbonate.

Results and Discussion
To develop the dM-Dmoc electrophilic ODN synthesis technology, the phosphoramidite monomers 3a–c and the linker 4
(Figure 1) were needed. The construction of linker 4 was reported previously [40]. The synthesis of 3a–c is shown in
Scheme 2. The reagent 5 needed for protecting the exo-amino
groups of nucleobases was prepared in two steps from 1,3dithiane (6) according to a procedure we reported previously
[44]. The dC phosphoramidite monomer 3a was synthesized
from compound 9 [45]. The formation of the hindered O-tertalkyl N-arylcarbamate 10 was found highly challenging
[44,46,47]. We tried many conditions and finally found that
acceptable yields could be achieved under the highly reactive

1117

Beilstein J. Org. Chem. 2019, 15, 1116–1128.

Scheme 1: Comparison of Dmoc and dM-Dmoc as nucleobase protecting groups for ODN synthesis.

Figure 1: dM-Dmoc phosphoramidite monomers and CPG with Dmoc linker.
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Scheme 2: Synthesis of compound 5 [44], nucleoside phosphoramidite monomers 3a–c and phosphoramidite capping agent 25.

conditions involving two equivalents LDA and one equivalent
5. The silyl protecting groups were then removed with TBAF
giving compound 11 in 99% yield. Tritylation of 11 with
DMTrCl gave 12, which was phosphitylated with reagents 13

and 14 to give the target monomer 3a (Scheme 2). The dA
phosphoramidite monomer 3b was synthesized similarly
starting from 15 [48]. The amino group of 15 was carbamylated
with 5 in the presence of two equivalents LDA to give 16. The
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silyl groups were removed, and compound 17 was tritylated to
give 18, which was phosphitylated to give 3b. The dG phosphoramidite monomer 3c had to be synthesized using a slightly
different procedure (Scheme 2). The amide function in the
nucleobase in the silyl protected nucleoside 19 [45] was
temporarily protected with TBSCl to give 20 [49]. This intermediate was not isolated and the exo-amino group was carbamylated directly with 5 in the presence of two equivalents LDA
giving 21 in 55% yield. The silyl protecting groups were removed to give 22, which was tritylated to give 23 and phosphitylated to give the target monomer 3c (Scheme 2). As will be
discussed later, we also needed the hydrophobic phosphoramidite 25 for developing the dM-Dmoc ODN synthesis technology. The compound was simply prepared from the commercially available 24 via phosphitylation using the reagents 13 and
14 (Scheme 2).
To demonstrate the capability of the dM-Dmoc ODN synthesis
technology for incorporating electrophilic groups, we also
needed phosphoramidite monomers 26a–c, which contained the
sensitive functionalities ester, α-chloroacetamide and thioester,
respectively (Figure 2). The synthesis of 26b,c has been reported [40]. Scheme 3 shows the synthesis of 26a. The required
1,2-diol 28 was simply prepared from the commercially available 27 by esterification in ethanol. Cyclization or oligomerization of 27 was not an issue for the transformation. The primary

alcohol of 28 was selectively tritylated with DMTrCl to give 29,
which was phosphitylated with 13 in the presence of 14 to give
26a.
With the required phosphoramidite monomers 3a–c and linker 4
in hand, we decided to identify suitable conditions for ODN
synthesis, deprotection and cleavage under non-nucleophilic
conditions by synthesizing the unmodified ODNs 30a,b
(Figure 3). The syntheses were conducted at a scale of
0.52 µmol on a MerMade 6 DNA/RNA synthesizer. The
dT-Dmoc-CPG (4) was used as the solid support. Detritylation
was carried out under standard conditions suggested by the
synthesizer manufacturer for 1 µmol synthesis. The 0.1 M
acetonitrile solutions of phosphoramidite monomers 3a–c and
the commercially available 5'-DMTr-β-cyanoethyl-dT phosphoramidite were used for incorporating dA, dC, dG and dT
nucleotides, respectively. The coupling conditions were standard except that in some cases, coupling was increased from
two to three times. Capping failure sequences was achieved
using the phosphoramidite 25 with 5-(ethylthio)-1H-tetrazole as
activator instead of the typically used acetic anhydride. Oxidation was performed under standard conditions. The last
nucleotide at the 5'-end of ODN was incorporated with a
5'-trityl nucleoside phosphoramidite instead of a 5'-DMTr counterpart. At the end of the synthesis, the 5'-trityl group was not
removed. More details about the synthesis are given in the Ex-

Figure 2: Structure of phosphoramidites containing electrophilic groups.

Scheme 3: Synthesis of ester-containing phosphoramidite 26a.
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Figure 3: ODN sequences 30a–e. Their 5'-tritylated versions are labeled as 30a-tr, 30b-tr, 30c-tr, 30d-tr, and 30e-tr, respectively.

perimental section. For cleavage and deprotection under nonnucleophilic conditions, the ODN on CPG, which should appear
as 31 (Scheme 4) with a 5'-trityl tag, was treated with a DBU
solution in acetonitrile at room temperature briefly. This removed the β-cyanoethyl phosphate protecting groups to give 32.
HPLC analysis of the DBU solution did not found any ODN
that was cleaved prematurely – an observation consistent with
the slow rate of cleavage of succinyl-anchored ODNs from
solid support under similar conditions [50]. The dithioketal
groups in the dM-Dmoc and Dmoc functions of 32 were then
oxidized with a solution of sodium periodate at room temperature to give 33. The 5'-trityl tag survived the conditions. It
should be pointed out that some sulfoxides might be further
oxidized to sulfones, which should not affect the overall results
of the deprotection and cleavage procedure. Removal of the
oxidized dM-Dmoc protection groups and cleavage of the
oxidized Dmoc linker were achieved with a solution of the
weak non-nucleophilic base potassium carbonate at pH 8 at
room temperature giving the fully deprotected 5'-trityl-tagged
ODN 30 (Scheme 4). Purification of the ODN 30a was
achieved in two steps – trityl-on RP HPLC followed by trityloff RP HPLC. For trityl-on HPLC (profile a, Figure 4), the
desired full-length 5'-trityl-tagged ODN appeared at 36–39
minutes, and was well separated from other peaks. This peak
was collected, and analyzed with RP HPLC (profile b). The
purified 5'-trityl-tagged ODN was detritylated with 80% acetic
acid. Even though it was reported that removal of trityl groups
from a primary alcohol required two days at room temperature

with 80% acetic acid [51], we found that our detritylation could
reach completion or in some cases close to completion in three
hours. After the acid was evaporated, the de-tritylated ODN was
purified again with RP HPLC (profile c). The major peak at
around 20 minutes was collected, the ODN from which showed
a single sharp peak when analyzed with RP HPLC (profile d).
The purified de-tritylated ODN was further analyzed with polyacrylamide gel electrophoresis (PAGE), a single band was observed (Lane 1, Figure 5). The HPLC purified ODN was also
analyzed with MALDI–TOF MS, molecular mass corresponding to correct ODN structure was found (Figure 6). The unmodified ODN 30b were synthesized, purified and analyzed under
the same conditions. Its HPLC profiles and MS are given in
Supporting Information File 2, and PAGE image is in Figure 5.
All the analytical data indicate that the ODNs were pure and
had correct identity.
In the RP HPLC profiles of the crude 5'-trityl-tagged ODNs
such as that for 30a-tr (profile a, Figure 4), besides failure sequences at around 20 minutes, there were multiple peaks after
40 minutes. We believe that those peaks were from branched
ODNs generated from the premature deprotection of dM-Dmoc
groups during ODN synthesis. The dM-Dmoc protections,
which contained a tertiary butyl carbamate moiety, were not
completely stable under the acidic conditions needed for
de-tritylation in each synthetic cycle. Once the protection was
lost, in the coupling step, incoming phosphoramidites would
react with the free amino groups, and branched ODNs would be
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Scheme 4: ODN deprotection and cleavage under non-nucleophilic conditions.
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Figure 4: RP HPLC profiles of (a) crude 30a-tr, (b) pure 30a-tr, (c) crude 30a, (d) pure 30a, (e) crude 30c-tr, (f) pure 30c-tr, (g) crude 30c, (h) pure
30c. In profiles (a) and (e), the well-separated major peak before 40 minutes is the trityl-tagged full-length ODN. The peaks after 40 minutes are
branched sequences with two or more trityl tags.

produced. Fortunately, these branched ODNs had two or more
5'-trityl groups, and therefore were significantly more hydrophobic than the desired ODN. During RP HPLC, they were
eluted significantly later than the desired ODN and could be
easily removed. We believe that the branching problem was not
caused by premature oxidation of the dM-Dmoc groups by
iodine in the oxidation step in ODN synthesis because the problem did not exist when Dmoc was used for ODN synthesis [41].
In addition, we also subjected 1,3-dithiane to the iodine oxidation conditions for over 24 hours, no oxidation could be
detected.
Figure 5: PAGE analyses of ODNs 30a–e. Lanes 1–5 are ODNs
30a–e, respectively.

Before using 25 for capping and a trityl group for 5'-tagging in
ODN synthesis using 3a–c and 4, we tried to synthesize ODNs
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conditions to remove the tag after purification of the ODN.
These experiments directed us to the use of the trityl tag to
assist ODN purification as described above. The reason for us
to use 25 instead of acetic anhydride for capping was based on
two considerations. One was that if a branched sequence failed
to react at one or more sites during coupling, capping with a
hydrophobic agent would still make the branched sequence
more hydrophobic than the desired full-length sequence.
Another consideration was that with acetic anhydride for
capping, chances existed for replacing the dM-Dmoc groups
with acetyl group during capping due to the presence of acids
such as pyridinium acetate and large excess of acetic anhydride.
Once the capping exchange occurred, the ODN molecule with
an acetyl group would not be useful because the acetyl group
would not be deprotectable under the mild deprotection conditions. Using 25 for capping, such capping exchange would not
occur.

Figure 6: MALDI–TOF MS of (a) ODN 30a and (b) 30c.

under standard conditions using acetic anhydride for capping
and without tagging the 5'-end of ODNs. RP HPLC analyses
showed that the peaks of the desired ODNs and branched sequences were very close and in some cases even overlapped,
which made HPLC purification of the products difficult. A
typical RP HPLC profile of ODNs synthesized in that manner is
given in Supporting Information File 2. We therefore tried to
keep the 5'-DMTr group at the end of solid phase synthesis to
assist HPLC purification hypothesizing that the desired ODN
with one DMTr group would be easy to be separated from any
branched sequences that had two or more DMTr groups. This
was indeed the case. A RP HPLC profile is given in Supporting
Information File 2. However, the sodium periodate oxidation
conditions used for ODN cleavage and deprotection were
slightly acidic, and in most cases, we were not able to keep the
DMTr groups. This problem made the method unreliable. We
also tried to tag the ODN with the hydrophobic tertbutyldiphenylsilyl (TBDPS) group. In RP HPLC profiles, the
desired TBDPS-tagged full-length sequence was also separated
very well from the branched sequences (Supporting Information File 2). However, at this time we could not identify mild

After identifying suitable conditions for the synthesis of unmodified ODNs under non-nucleophilic conditions using the
dM-Dmoc technology, studying the feasibility of the technology for the synthesis of modified ODNs containing ester,
α-chloroacetamide and thioester groups was pursued. These
groups are sensitive to nucleophiles and cannot survive the
commonly used concentrated ammonium hydroxide deprotection and cleavage conditions. We have demonstrated that the so
called UltraMild deprotection and cleavage conditions involving potassium carbonate in anhydrous methanol are incompatible with α-chloroacetamide and thioester [40]. These findings
are easily understandable because the species responsible for
the cleavage and deprotection under UltraMild conditions is
potassium methoxide, which is a strong nucleophile. The ODNs
30c–e were chosen as the targets for the current study. The synthesis, deprotection and cleavage conditions were the same as
those for the unmodified ODNs. The electrophilic groups were
introduced with 26a–c, respectively. In all cases, we placed the
groups in the middle of the sequences, which is significantly
more challenging than placing them at the 5'-end. The fully
deprotected crude ODNs 30c–e were purified and analyzed as
described for 30a. The HPLC profiles of crude and pure 30c are
given in Figure 4. Its PAGE and MALDI–TOF MS images are
in Figure 5 and Figure 6, respectively. All analytical data for
30d,e are given in Supporting Information File 2. It is noted that
aminolysis and hydrolysis of the sensitive groups in the ODNs,
which were found to be a problem previously [41], were successfully avoided by using the dM-Dmoc protection strategy.
For all the five ODNs (30a–e), their OD260 after HPLC purification were determined (Supporting Information File 2). They
ranged from 2.32 to 6.68 for the 0.52 µmol syntheses. To have a
direct comparison with standard ODN synthesis technology, we
also synthesized 30a using commercial phosphoramidites and
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0.52 µmol 4 (Supporting Information File 2). After purification
with RP HPLC, the OD260 of 30a was determined to be 8.30.
With these data, we were able to conclude that the dM-Dmoc
phosphoramidites had similar coupling efficiency as commercial phosphoramidites and the overall yields of ODNs from the
dM-Dmoc technology were at the same level of those from
standard technologies.
The successful synthesis and HPLC purification of the above
five ODNs demonstrated that dM-Dmoc is a viable choice for
amino protection for electrophilic ODN synthesis. Compared
with using Dmoc for ODN synthesis, the major advantage of
using dM-Dmoc is that deprotection can be achieved without
using any nucleophilic scavengers. Using Dmoc, during deprotection after sodium periodate oxidation, a large excess aniline
is needed to induce the β-elimination (see Scheme 1) and to
prevent the side product 1 from reacting with the deprotected
ODN via Michael addition [40]. Aniline is a weak base and
only mildly nucleophilic. Electrophiles that are compatible with
ODNs but reactive toward it are rare. However, using a large
excess of aniline could be a significant drawback. For example,
many electrophiles could be considered unreactive to it, but in
the presence of a large excess of it, problems might arise. In addition, its boiling point is high, alternative techniques other than
simple evaporation has to be used for its removal. In order to
accomplish our goal of developing a universally useful technology for electrophilic ODN synthesis, the dM-Dmoc technology
is a logical extension of our previous effort [40]. Using
dM-Dmoc, the side product of deprotection is 2. We believe
that 2 could not react with the nucleophiles on ODNs including
hydroxy and amino groups. Even the reaction took place, a
hindered four-substituted carbon center would be formed.
Because the Michael addition reaction is reversible, the adducts
would easily fall apart to give back un-modified ODNs. Indeed,
due to the use of dM-Dmoc, we were able to induce β-elimination with potassium carbonate in the absence of any scavenger
under mild conditions.
Besides the advantage of avoiding the use of excess aniline as a
scavenger, in the new studies, we also found that the acetic acid
used in our previous studies for sodium periodate oxidation
could be omitted. In that report [40], for oxidation of the
dithioketals in Dmoc, an acidic solution of sodium periodate
adjusted to pH 2 with acetic acid was used. Under those conditions, β-elimination did not occur and the ODNs remained on
the solid support during oxidation. This greatly facilitated the
removal of excess sodium periodate and its reduced salts
because they could be easily washed away with water. Otherwise, more expensive means such as size exclusion chromatography had to be used. In our new studies, we tested to perform
the oxidation in the absence of acetic acid. We found that the

pH of 0.4 M sodium periodate solution was around 4, and this
solution did not cause premature β-elimination during oxidation. Therefore, the ODNs remained on the solid support under
this significantly less acidic conditions. Because ODNs are
inherently unstable under acetic conditions, avoiding the use of
acetic acid and performing the cleavage and deprotection at
nearly neutral pH could make the technology more useful. In
addition, the scope of sensitive functionalities to be introduced
to ODNs using the technology could be further extended. The
finding of the stability of the Dmoc function in linker 4 after oxidation under nearly neutral conditions is also important for
considering using the technology for oligoribonucleotides
(ORNs) synthesis. One potential problem to use the technology
for ORN synthesis is that during oxidation of the Dmoc and
dM-Dmoc functions using sodium periodate, if the oxidized
Dmoc in the linker were unstable, and the 2' and 3'-OH groups
were exposed before sodium periodate were removed, the C–C
bond between the 2' and 3' carbons could be cleaved. With the
finding of the relatively high stability of the oxidized Dmoc
function, we are more confident that the Dmoc associated technologies will be useful for ORN synthesis as well.

Conclusion
In summary, we have extended the Dmoc-based electrophilic
ODN synthesis technology to a new level, at which dM-Dmoc
is used for protecting exo-amino groups of nucleobases. With
this advancement, the previously used large excess aniline for
scavenging the Michael acceptor side product during cleavage
and deprotection was no longer needed. This makes the technology more convenient to use and could extend its scope on incorporating different sensitive functionalities into ODNs. In addition, we found that the sodium periodate oxidation step for
cleavage and deprotection could be performed in the absence of
acetic acid at nearly neutral conditions instead of previously
used acidic conditions. Because ODNs and many functionalities are sensitive to acid, the significantly less acidic conditions
will eliminate concerns of ODN damage and increase the scope
of functionalities capable to be incorporated into ODNs. Using
the technology, five ODNs including three modified ones containing the sensitive groups – ester, α-chloroamide and thioester
– were successfully synthesized. We expect that the technology
will become a useful tool for the synthesis of sensitive ODN
analogs.

Experimental
ODN synthesis, deprotection, cleavage and characterization:
All ODNs were synthesized on dT-Dmoc-CPG [40] (4,
26 µmol/g loading, 20 mg, 0.52 µmol) using a MerMade 6
Synthesizer. dM-Dmoc phosphoramidites 3a–c and the commercial 5'-DMTr-2-cyanoethyl-dT phosphoramidite were used
as monomers. The conditions suggested by synthesizer manu-
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facturer for 1 μmol synthesis were used except that coupling
was optionally increased from 2 to 3 times and capping was
achieved using 25 instead of acetic anhydride. Briefly, detritylation, DCA (3%, DCM), 90 s × 2; coupling, phosphoramidite
(0.1 M, MeCN), 5-(ethylthio)-1H-tetrazole (0.25 M, MeCN),
60 s × 3 (or 2); capping, 25 (0.1 M, MeCN) and 5-(ethylthio)1H-tetrazole (0.25 M, MeCN), 60 s × 3; oxidation, I2 (0.02 M,
THF/pyridine/H2O, 70/20/10, v/v/v), 40 s. For incorporating the
last nucleoside monomer, a 5'-trityl-2-cyanoethyldeoxynucleoside phosphoramidite instead of the 5'-DMTr counterpart (in the
current cases, 2'-deoxy-5'-O-tritylthymidine-3'-O-N,N-diisopropylaminocyanoethylphosphoramidite [52] was used) was
used. At the end of synthesis, the 5'-trityl group was kept. The
CPG was divided into 10 equal portions. One portion was
gently shaken in a solution of DBU/CH3CN (1:9, v/v, 1 mL) at
rt for 15 min. The supernatant was removed with a pipette, and
the CPG was washed with CH3CN (1 mL × 5). This removed
the 2-cyanoethyl groups on the phosphate groups. To the CPG,
aqueous NaIO4 (0.4 M, 1 mL) was added and the mixture was
shaken at rt for 3 h. The supernatant was removed with a
pipette, and the CPG was rinsed briefly with water (1 mL × 4).
Alternatively, oxidation was achieved with 0.1 M NaIO4 (1 mL,
rt, 1 h × 3). The CPG was then washed with H2O (1 mL × 4).
This oxidized the dithioketals in the dM-Dmoc and Dmoc
groups. HPLC analysis of the supernatant and washes indicated
that the ODN was not cleaved from CPG at this time. To the
CPG was added aqueous K2CO3 (0.05%, pH 8, 500 μL), and
the mixture was shaken at rt for 30 min. The supernatant was
transferred into a centrifugal tube. The process was repeated
one time. The combined supernatant was concentrated to
≈100 μL and injected into RP HPLC to generate crude ODN
trace [in some trials, before HPLC the combined supernatant
(1 mL) was loaded on a polyacrylamide desalting column
(10 mL) and eluted with H 2 O to remove the salts from the
ODN]. Fractions of the major ODN peak at ≈39 min were
collected, concentrated to ≈100 μL, and injected into HPLC to
give the profile of purified trityl-tagged ODN. To the dried
trityl-tagged ODN was added 1 mL of 80% AcOH, and the mixture was shaken gently at rt for 3 h. Volatiles were evaporated.
The residue was dissolved in ≈100 μL water, and injected into
RP HPLC. The major peak of de-tritylated ODN at ≈21 min
was collected and concentrated to dryness. The residue was the
pure de-tritylated ODN, which was dissolved in 100 μL water
and injected into HPLC to generate the profile of pure de-tritylated ODN. The pure ODN was analyzed with PAGE and
MALDI–TOF MS. Information about OD 260 of the ODNs
(30a–e) and a comparison of the synthesis yields of 30a using
the dM-Dmoc (OD260 of 0.52 µmol synthesis, 2.94) and standard (OD260 of 0.52 µmol synthesis, 8.30) ODN synthesis technologies are provided in the UV spectra section of the Supporting Information File 2.
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protocol for ODN cleavage and deprotection.
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